A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
This study has been completed.
Sponsor:
Rush University Medical Center
Collaborators:
GlaxoSmithKline
Millennium Pharmaceuticals, Inc.
Information provided by:
Rush University Medical Center
ClinicalTrials.gov Identifier:
NCT00479167
First received: May 24, 2007
Last updated: February 4, 2009
Last verified: February 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2008 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |